Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 01/14/20
Due: 01/14/21
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/15
Due: 12/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery | NCT01988246 | Rishi Singh | user2@example.com | None | 2013-12-31 | 2020-01-14 | 2021-01-14 | - | - | 2025-07-14 |
| Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab | NCT02559180 | Rishi Singh | user2@example.com | None | 2015-10-31 | 2020-12-31 | 2021-12-31 | - | - | 2025-07-14 |
| Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept | NCT01617148 | Rishi Singh | user2@example.com | None | 2012-06-30 | 2015-12-31 | 2016-12-31 | - | - | 2025-07-14 |